Clinical trial
Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study…
NCT00001409 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001409 |
|---|---|
| Title | Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications |
| Official title | A Phase I/II Pilot Study of the Safety of the Adoptive Transfer of Syngeneic Gene-Modified Cytotoxic T Lymphocytes in HIV Infected Identical Twins |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Acquired Immunodeficiency Syndrome, HIV Infection |
| Intervention type | Drug |
| Interventions | Interleukin-2 |
| Enrollment | 100 |
| Start date | Sep 1, 1994 |
| Completion | Jun 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: